Author’s Reply to Vaz et al.: “Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease”
Yonghui Fu(Jiangxi Mental Health Center), Wenfeng He(Macau University of Science and Technology), He Chen(Beijing Normal University), Wengen Zhu(Sun Yat-sen University), Yue Zhou(Qingdao University), Lan Yan(Jiangxi Mental Health Center)
Cited by 0
Related Papers
The <scp>HAS‐BLED</scp> Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta‐analysis
|Clinical Cardiology|2015|227
Bioactivities and Health Benefits of Wild Fruits
|International Journal of Molecular Sciences|2016|188
Effects and Mechanisms of Fruit and Vegetable Juices on Cardiovascular Diseases
|International Journal of Molecular Sciences|2017|176
Interplay between microRNAs and the STAT3 signaling pathway in human cancers
|Physiological Genomics|2013|106
Tetrandrine blocks autophagic flux and induces apoptosis via energetic impairment in cancer cells
|Cell Death and Disease|2014|87